Physician profile
Arthur Law
NPI 1629006515
$658.31
in general payments reported to CMS, 2019-2025
11 companies · $218 in 2025
The $218 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2022: $63.87 · 2023: $83.76 · 2024: $166 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $192.49 | 2022-2025 | Bexsero, Penmenvy |
| Merck Sharp & Dohme LLC | $108.11 | 2019-2025 | M-M-R II, Gardasil 9, Proquad |
| Kaleo, INC. | $91.79 | 2019-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $82.92 | 2024-2025 | |
| Pfizer INC. | $48.05 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $39.49 | 2023 | Dupixent |
| Exeltis, USA INC. | $23.78 | 2025 | Slynd |
| Phadia US INC. | $22.21 | 2023 | Immunocap |
| Cranial Technologies, INC | $19.37 | 2025 | Doc Band |
| Kyowa Kirin, INC. | $17.67 | 2024 | Crysvita |
| Qiagen, LLC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.